VAPO
Get informed when a big investor buys or sells
+ FollowUndervalued by 75.9% based on the discounted cash flow analysis.
| Market cap | $13.55 Million |
|---|---|
| Enterprise Value | $129.05 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-9.64 |
| Beta | -1.1 |
| Outstanding Shares | 6,442,763 |
| P/E Ratio | -0.23 |
|---|---|
| PEG | 6.44 |
| Price to Sales | 0.2 |
| Price to Book Ratio | -0.17 |
| Enterprise Value to Revenue | 1.82 |
| Enterprise Value to EBIT | -4.12 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.92 |
| Debt to Equity | -1.46 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Vapotherm, Inc. is a developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, USA. The company develops innovative, comfortable, non-invasive technologies for respiratory support of patients with chro...